Induction, maintenance bortezomib improved survival in newly diagnosed ... Healio Patients were assigned to induction vincristine, doxorubicin and dexamethasone (n=414) or bortezomib (Velcade, Millennium Pharmaceuticals), doxorubicin and dexamethasone (n=413), followed by high-dose melphalan and autologous stem cell transplant. |
